企業プロフィール
23andMe 株価・ニュース・カタリスト
- ティッカー:
- ME
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for ME.
企業概要
事業概要
23andMe is a consumer genetics and research company built around genetic testing, data services, and health-related insights. Its model is rooted in consumer engagement more than drug development.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, 23andMe sits in consumer genetics and health data.
ビジネスモデルの特徴
The business depends on consumer subscriptions, data monetization, and the ability to turn genetics into recurring value.
バイオ業界での位置付け
23andMe is outside biotech proper and is better viewed as a consumer genetics and health-data platform.
今後のカタリスト
- 23andMe's catalysts are asset sales, balance-sheet actions, and any move that clarifies how consumer genetics and data fit into the next business model. The company is now more of a restructuring story than a growth story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。